GlassScriptPhysician profile
William J Polinski
NPI 1104897990
$5,579.18
in general payments reported to CMS, 2019-2025
18 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $176 · 2021: $38.77 · 2022: $1,790 · 2023: $906 · 2024: $2,019 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,842 · Food and Beverage: $1,096 · Education: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,841.75 |
| Food and Beverage | $1,096.41 |
| Education | $131.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,718.20 | 2023-2024 | Micra, Selectsecure |
| Boston Scientific Corporation | $1,699.43 | 2020-2025 | Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor |
| Medtronic Vascular, INC. | $273.49 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $230.27 | 2021-2025 | Atacand, Farxiga |
| Abbott Laboratories | $156.23 | 2020-2024 | Confirm Rx |
| E.R. Squibb & Sons, L.L.C. | $86.38 | 2019-2024 | Camzyos |
| Novartis Pharmaceuticals Corporation | $71.26 | 2019-2024 | |
| Abiomed | $64.38 | 2019 | |
| Pfizer INC. | $54.28 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.92 | 2019-2022 | |
| Bardy Diagnostics, INC. | $40.00 | 2019 | |
| Heartflow, INC. | $28.29 | 2025 | |
| Cardiovascular Systems INC. | $24.38 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.28 | 2025 | Lifevest |
| Scpharmaceuticals INC. | $18.23 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $17.62 | 2025 | Repatha |
| Argon Medical Devices, INC. | $15.04 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Polinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.